Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arch Therapeutics Inc (ARTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 85,664
  • Shares Outstanding, K 161,630
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,790 K
  • 36-Month Beta 0.84
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 37.65
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/19/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3010 +82.03%
on 11/21/18
0.5790 -5.37%
on 12/14/18
+0.1879 (+52.19%)
since 11/14/18
3-Month
0.3010 +82.03%
on 11/21/18
0.5790 -5.37%
on 12/14/18
+0.0979 (+21.76%)
since 09/14/18
52-Week
0.2500 +119.16%
on 12/18/17
0.7618 -28.08%
on 12/15/17
-0.1841 (-25.15%)
since 12/14/17

Most Recent Stories

More News
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, presented an update on its corporate milestones, plans and timetables...

ARTH : 0.5479 (+3.38%)
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is pleased to announce that the Japanese Intellectual Property...

ARTH : 0.5479 (+3.38%)
Arch Therapeutics Announces Submission of CE Mark File for AC5(TM) Topical Hemostat in Europe

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company has submitted the required...

ARTH : 0.5479 (+3.38%)
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company submitted a 510(k) notification...

ARTH : 0.5479 (+3.38%)
Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced topline data for its irritation/sensitization patch...

ARTH : 0.5479 (+3.38%)
Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 8 LD Micro Invitational....

ARTH : 0.5479 (+3.38%)
Arch Therapeutics Provides Update on Study Initiation and 510(k)

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it will initiate the previously disclosed study...

ARTH : 0.5479 (+3.38%)
Arch Therapeutics Provides Update on 510(k)

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it has utilized the Food and Drug Administration's...

ARTH : 0.5479 (+3.38%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies...

KSHB : 5.7200 (+0.35%)
EVLLF : 0.6974 (-2.32%)
OPRX : 11.95 (+3.02%)
DMIFF : 0.2099 (-19.42%)
CORVF : 1.9387 (-4.21%)
IMPZY : 0.7400 (-8.07%)
CHPE : 19.2500 (-1.18%)
CBWTF : 0.5799 (-2.37%)
ATMS : 0.8450 (+212.85%)
RSSS : 2.6200 (+0.77%)
FSSN : 0.1490 (+2.76%)
MSRT : 0.0910 (-5.21%)
GPVRF : 0.3100 (unch)
QBIO : 1.7000 (unch)
SNYR : 0.1959 (+42.99%)
ACBFF : 8.6900 (-12.80%)
CVSI : 4.8100 (+2.01%)
RSASF : 0.1315 (-4.43%)
COSM : 4.1000 (-18.00%)
GRWG : 2.8900 (+3.21%)
GTBP : 0.8160 (+2.00%)
ZYXI : 3.0300 (-2.26%)
PURE : 0.5000 (+4.17%)
CXDO : 2.5500 (+17.51%)
BCTXF : 0.0627 (-13.52%)
TAOIF : 0.2460 (-5.38%)
BNOEF : 0.0900 (unch)
NMKEF : 0.5626 (+0.02%)
CNNRF : 5.7461 (-11.05%)
ZEST : 0.7400 (-5.13%)
HEOFF : 0.6700 (-9.45%)
ITHUF : 4.3200 (+2.37%)
COTQF : 0.0362 (-20.96%)
OTCM : 29.1500 (-0.34%)
DCTH : 0.3481 (+2.38%)
AEYE : 7.00 (-1.41%)
VFFIF : 3.9300 (-1.75%)
TITXF : 0.1930 (-1.03%)
NMGRF : 0.2081 (+0.14%)
GLDLF : 0.5600 (unch)
SNNVF : 2.4000 (-5.88%)
IWSY : 0.7700 (-6.10%)
ARTH : 0.5479 (+3.38%)
IRNC : 0.2650 (+6.00%)
PNGZF : 0.1516 (+5.28%)
NTSFF : 0.5610 (-1.04%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market...

EVLLF : 0.6974 (-2.32%)
KSHB : 5.7200 (+0.35%)
DMIFF : 0.2099 (-19.42%)
OPRX : 11.95 (+3.02%)
CORVF : 1.9387 (-4.21%)
IMPZY : 0.7400 (-8.07%)
CBWTF : 0.5799 (-2.37%)
CHPE : 19.2500 (-1.18%)
ATMS : 0.8450 (+212.85%)
RSSS : 2.6200 (+0.77%)
FSSN : 0.1490 (+2.76%)
MSRT : 0.0910 (-5.21%)
GPVRF : 0.3100 (unch)
QBIO : 1.7000 (unch)
SNYR : 0.1959 (+42.99%)
ACBFF : 8.6900 (-12.80%)
CVSI : 4.8100 (+2.01%)
COSM : 4.1000 (-18.00%)
RSASF : 0.1315 (-4.43%)
GTBP : 0.8160 (+2.00%)
ZYXI : 3.0300 (-2.26%)
GRWG : 2.8900 (+3.21%)
PURE : 0.5000 (+4.17%)
CXDO : 2.5500 (+17.51%)
BCTXF : 0.0627 (-13.52%)
TAOIF : 0.2460 (-5.38%)
BNOEF : 0.0900 (unch)
NMKEF : 0.5626 (+0.02%)
CNNRF : 5.7461 (-11.05%)
ITHUF : 4.3200 (+2.37%)
HEOFF : 0.6700 (-9.45%)
ZEST : 0.7400 (-5.13%)
COTQF : 0.0362 (-20.96%)
OTCM : 29.1500 (-0.34%)
DCTH : 0.3481 (+2.38%)
AEYE : 7.00 (-1.41%)
TITXF : 0.1930 (-1.03%)
VFFIF : 3.9300 (-1.75%)
NMGRF : 0.2081 (+0.14%)
GLDLF : 0.5600 (unch)
SNNVF : 2.4000 (-5.88%)
IWSY : 0.7700 (-6.10%)
ARTH : 0.5479 (+3.38%)
IRNC : 0.2650 (+6.00%)
PNGZF : 0.1516 (+5.28%)
NTSFF : 0.5610 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ARTH with:

Key Turning Points

2nd Resistance Point 0.6213
1st Resistance Point 0.5846
Last Price 0.5479
1st Support Level 0.5056
2nd Support Level 0.4633

See More

52-Week High 0.7618
Fibonacci 61.8% 0.5663
Last Price 0.5479
Fibonacci 50% 0.5059
Fibonacci 38.2% 0.4455
52-Week Low 0.2500

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar